261 related articles for article (PubMed ID: 11875695)
1. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM; Baas P; Manegold Ch; Schouwink JH; Burgers JA; de Bruin HG; Mooi WJ; van Klaveren RJ; de Jonge MJ; van Meerbeeck JP
Br J Cancer; 2002 Feb; 86(3):342-5. PubMed ID: 11875695
[TBL] [Abstract][Full Text] [Related]
2. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
Nowak AK; Byrne MJ; Williamson R; Ryan G; Segal A; Fielding D; Mitchell P; Musk AW; Robinson BW
Br J Cancer; 2002 Aug; 87(5):491-6. PubMed ID: 12189542
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.
Kovac V; Zwitter M; Rajer M; Marin A; Debeljak A; Smrdel U; Vrankar M
Anticancer Drugs; 2012 Feb; 23(2):230-8. PubMed ID: 22027538
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
Kalmadi SR; Rankin C; Kraut MJ; Jacobs AD; Petrylak DP; Adelstein DJ; Keohan ML; Taub RN; Borden EC
Lung Cancer; 2008 May; 60(2):259-63. PubMed ID: 18006112
[TBL] [Abstract][Full Text] [Related]
5. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Pinto C; Marino A; De Pangher Manzini V; Benedetti G; Galetta D; Mazzanti P; Del Conte G; dell'Amore D; Piana E; Giaquinta S; Lopez M; Martoni A
Lung Cancer; 2006 May; 52(2):199-206. PubMed ID: 16542747
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
Byrne MJ; Davidson JA; Musk AW; Dewar J; van Hazel G; Buck M; de Klerk NH; Robinson BW
J Clin Oncol; 1999 Jan; 17(1):25-30. PubMed ID: 10458214
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
Habib EE; Fahmy ES
Clin Transl Oncol; 2013 Nov; 15(11):965-8. PubMed ID: 23408040
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.
Ralli M; Tourkantonis I; Makrilia N; Gkini E; Kotteas E; Gkiozos I; Katirtzoglou N; Syrigos K
Anticancer Res; 2009 Aug; 29(8):3441-4. PubMed ID: 19661370
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.
Favaretto AG; Aversa SM; Paccagnella A; Manzini Vde P; Palmisano V; Oniga F; Stefani M; Rea F; Bortolotti L; Loreggian L; Monfardini S
Cancer; 2003 Jun; 97(11):2791-7. PubMed ID: 12767092
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.
Castagneto B; Zai S; Dongiovanni D; Muzio A; Bretti S; Numico G; Botta M; Sinaccio G
Am J Clin Oncol; 2005 Jun; 28(3):223-6. PubMed ID: 15923792
[TBL] [Abstract][Full Text] [Related]
12. Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma.
Utkan G; Büyükçelik A; Yalçin B; Akbulut H; Demirkazik A; Dinçol D; Onur H; Gören D; Mousa U; Senler FC; Içli F
Lung Cancer; 2006 Sep; 53(3):367-74. PubMed ID: 16828196
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N
Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265
[TBL] [Abstract][Full Text] [Related]
14. Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Kindler HL; Karrison TG; Gandara DR; Lu C; Krug LM; Stevenson JP; Jänne PA; Quinn DI; Koczywas MN; Brahmer JR; Albain KS; Taber DA; Armato SG; Vogelzang NJ; Chen HX; Stadler WM; Vokes EE
J Clin Oncol; 2012 Jul; 30(20):2509-15. PubMed ID: 22665541
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.
Tourkantonis I; Makrilia N; Ralli M; Alamara C; Nikolaidis I; Tsimpoukis S; Charpidou A; Kotanidou A; Syrigos K
Am J Clin Oncol; 2011 Feb; 34(1):38-42. PubMed ID: 20142722
[TBL] [Abstract][Full Text] [Related]
16. Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma.
Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Aoki Y; Wataya H; Asoh H; Ichinose Y
Jpn J Clin Oncol; 2005 Aug; 35(8):433-8. PubMed ID: 16006571
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
[TBL] [Abstract][Full Text] [Related]
18. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
Lee CW; Murray N; Anderson H; Rao SC; Bishop W
Lung Cancer; 2009 Jun; 64(3):308-13. PubMed ID: 19004520
[TBL] [Abstract][Full Text] [Related]
19. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial.
Ceresoli GL; Aerts JG; Dziadziuszko R; Ramlau R; Cedres S; van Meerbeeck JP; Mencoboni M; Planchard D; Chella A; Crinò L; Krzakowski M; Rüssel J; Maconi A; Gianoncelli L; Grosso F
Lancet Oncol; 2019 Dec; 20(12):1702-1709. PubMed ID: 31628016
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma.
Portalone L; Antilli A; Nunziati F; Crispino C; de Marinis F; Friggeri L; Lombardi A; Lorusso V; Pronzato P; Sambiasi D; Signora M;
Tumori; 2005; 91(1):15-8. PubMed ID: 15849999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
